Weight Loss Drug Reported to Reverse Diabetes

Proper greatergood_ctg_belowtitle

EmaxHealth Health News

By Robin Wulffson MD for EmaxHealth.com

DUBAI, UNITED EMIRATES––An investigational weight loss drug was reported to reverse type 2 diabetes; the results were presented at the International Diabetes Federation World Diabetes Congress 2011 (December 4-8; Dubai, United Arab Emirates) The medication, which has the proposed name Qnexa, was rejected by the US Food and Drug Administration (FDA) last year. Qnexa is a controlled-release combination of phentermine, an appetite suppressant, and topiramate, an anticonvulsant.

“We need more options to treat the twin epidemics of diabetes and obesity,” said Nancy J.V. Bohannon, MD, director of clinical research in the cardiovascular risk reduction program at St. Luke’s Hospital (San Francisco, California), who presented the findings. She noted, “This could potentially be an approach that is nonsurgical for treating obesity and improving glycemic control.” Dr. Bohannon, who is a consultant to, serves on the advisory board of, and holds stock in Vivus (Mountain View, California), the company that manufactures the drug.

“LIKE” EmaxHealth news on Facebook to receive links to important articles in your Facebook feed!

Australian Bushfires Have Caused Uptick in Hypoglycemic Episodes, Ambulance Rides, and More: Click “Next” below!

The Diabetes Site is a place where people can come together to help those whose lives have been affected by diabetes. In addition to sharing inspiring stories, shopping for the cause, and signing petitions, visitors can take just a moment each day to c lick on the red button to provide much-needed support for diabetes research. Visit The Diabetes Site and click today - it's free!
Proper greatergood_ctg_belowcontent